SCHEMBL7833153

SCHEMBL7833153

COc1ccc(Cn2cc(C)c(=O)[nH]c2=O)cc1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.70
MAPK1 P28482 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5126430 0.84 HPGD (0.74) HPGDMAPK1
SCHEMBL7840035 0.84 MEN1 (0.71) HPGD
SCHEMBL12501015 0.84 MEN1 (0.49) HPGD
SCHEMBL7839293 0.84 TYMP (0.52) HPGD
SCHEMBL5123986 0.83 HPGD (0.72) HPGDMAPK1
SCHEMBL5117502 0.83 HPGD (0.72) HPGDMAPK1
SCHEMBL14232070 0.83 HPGD (0.72) HPGDMAPK1
SCHEMBL3996660 0.83 HPGD (1.00) HPGDMAPK1
SCHEMBL14208529 0.82 HPGD (0.70) HPGDMAPK1
SCHEMBL592220 0.81 HPGD (0.48) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed